Abstract:Objective: To study the number of CD4+CD25+ Treg and the expression of Foxp3 mRNA in thymus and spleen in mice with Lewis lung cancer, and investigate the role of CD4+CD25+ Treg in tumor immunological tolerance. Methods: The models were established by injected subcutaneously to the right axilla of C57BL/6 mice with subculturing Lewis lung cancer cells. The rate of tumor forming, tumor weight, the dynamic change of tumor volume were observed. The changes of T lymphocyte proliferation in thymus and spleen were detected by MTT test .The changes of number of CD4+CD25+ Treg were detected by flow cytometer and the expression of Foxp3 in thymus and spleen were analyzed by semi-quantitative RT-PCR. Results: The rate of tumor forming was 100%, tumor weight was 3.34 1.79g. The changes of T lymphocyte proliferation in thymus was lower in the tumor mice than in the normal mice, but not significantly like in splenic lymphocytes(P0.05). The changes of T lymphocyte proliferation in spleen was significantly lower in the tumor mice than in the normal mice(P0.05). The number of CD4+CD25+ Treg in thymus and spleen of mice was markedly higher in the tumor mice than in the normal mice(P0.05). The expression of Foxp3 mRNA in thymic lymphocyte was significantly higher in tumor mice (P0.05).The expression of Foxp3 mRNA in splenic lymphocyte was also shown higher in tumor mice than normal mice, but not significantly like in thymic lymphocytes(P0.05). Conclusion: CD4+CD25+regulatory T cell might be responsible for immune suppression in the tumor immunity and play it's function in tumor tolerance.

The Expression and Clinical Significance of CD4+ CD25+ Treg in Mice with Lewis Lung Cancer